EyePoint Pharmaceuticals
EYPT
EYPT
39 hedge funds and large institutions have $19.8M invested in EyePoint Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less capital invested
Capital invested by funds: $20M → $19.8M (-$151K)
Holders
39
Holding in Top 10
–
Calls
$575K
Puts
$216K
Top Buyers
| 1 | +$458K | |
| 2 | +$388K | |
| 3 | +$153K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$56.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$45.6K |
Top Sellers
| 1 | -$175K | |
| 2 | -$91K | |
| 3 | -$58K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$56K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$50.7K |